Synergistic formulation of SuperFood with Super Antioxidant provides
'brain+body' protection from dietary and environmental stress
ORLANDO, Fla., Oct. 21 /PRNewswire/ -- Valensa International (Orlando, USA) and Parry Nutraceuticals (Chennai, India) are jointly introducing a new organic dietary supplement called SpiruZan(TM) -- a synergistic complex of organic spirulina and astaxanthin in a single tablet presentation. SpiruZan combines the remarkable nutritional properties of organic spirulina with the superior antioxidant properties of astaxanthin to deliver a 'brain+body' supplement that offers protection from the stresses placed on people by dietary and environmental conditions. SpiruZan will be initially available as a 500 mg caplet providing 1.0 mg astaxanthin in a 3.0 g organic spirulina serving. SpiruZan is ideally suited for dieters, baby-boomers, vegetarians and people who live fast-paced, stressful lifestyles. It can also serve as the 'supplement of choice' for consumers who want to keep their supplement programs simple yet effective. This 100% natural and vegetarian supplement made from organic microalgae is a 'green food' that offers the added benefit of being 'sustainable nutrition.' Parry Nutraceuticals is the world's leading producer of certified organic spirulina. Valensa's astaxanthin was the first astaxanthin product approved as a Novel Food in Europe. The synergistic spirulina/astaxanthin formulation is under patent by Valensa. It will be marketed by both companies. The new product will be unveiled for the first time at the Supply Side West show in Las Vegas, NV.
According to Dr. Rudi E. Moerck, President of Valensa, SpiruZan is an excellent dietary supplement for helping people with lifestyles that are not always the most conducive to optimal health. "The nutrition+antioxidant package offered by SpiruZan is unique in the supplement industry -- because both ingredients are effective in supporting human health. It is a great product for vegetarians because it offers higher levels of complete protein than soy or red meat and good levels of vitamin B12. For dieters, SpiruZan offers more vitamin A than carrots, more iron than meat as well as essential fatty acids like GLA and minerals like potassium and calcium," he said. "Beyond these nutritional advantages, SpiruZan can help support eye health, cardiovascular health and central nervous system health because of the complete xanthophyll carotenoid package. It offers support to the immune system and provides anti-inflammatory support -- both of which are critical to overall general health, particularly in people who are getting older or who 'burn the candle at both ends.' SpiruZan is an excellent product to help people face the stresses of the modern world," he added.
Two Leaders Working Together
SpiruZan represents the first time that Parry Nutraceuticals and
Valensa International will be working together on a product for the human
health & nutrition market. The new product combines Parry's expertise in
microalgae with Valensa's extraction, formulation and product development
expertise. Parry Nutraceuticals produces an organic spirulina that is free
from pesticides, herbicides and artificial fertilizers. Valensa's
astaxanthin ingredients are manufactured using the company's
DeepExtract(TM) Ultra-High Pressure Supercritical CO2 Extraction and
O2B(TM) Peroxidation Blocker technology. According to Sebastian Thomas,
Chief Executive of Parry Nutraceuticals, the companies have similar
philosophies on the issues of quality, natural ingredients made using the
best technology. "Valensa International shares Parry Nutraceuticals'
commitment to creating the highest quality products based on the best
available science for the human health and nutrition market," Mr. Thomas
said. "We believe that consumers will always select an ingredient they know
they can trust when they are given the choice," Mr. Thomas added.
For information, contact:
Sid Hulse, Vice President, Marketing & Sales, Valensa
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
|SOURCE Valensa International|
Copyright©2008 PR Newswire.
All rights reserved